157 related articles for article (PubMed ID: 9234335)
1. A kinetic comparison of [18F]2-fluoro-2-deoxyglucose and [18F]2-fluoro-2-deoxymannose using positron emission tomography.
Braun AR; Carson RE; Adams HR; Finn RD; Francis BE; Herscovitch P
Nucl Med Biol; 1994 Aug; 21(6):857-63. PubMed ID: 9234335
[TBL] [Abstract][Full Text] [Related]
2. Estimation of local cerebral glucose utilization by positron emission tomography: comparison of [18F]2-fluoro-2-deoxy-D-glucose and [18F]2-fluoro-2-deoxy-D-mannose in patients with focal brain lesions.
Wienhard K; Pawlik G; Nebeling B; Rudolf J; Fink G; Hamacher K; Stöcklin G; Heiss WD
J Cereb Blood Flow Metab; 1991 May; 11(3):485-91. PubMed ID: 2016357
[TBL] [Abstract][Full Text] [Related]
3. Experimental study for cancer diagnosis with positron-labeled fluorinated glucose analogs: [18F]-2-fluoro-2-deoxy-D-mannose: a new tracer for cancer detection.
Fukuda H; Matsuzawa T; Abe Y; Endo S; Yamada K; Kubota K; Hatazawa J; Sato T; Ito M; Takahashi T; Iwata R; Ido T
Eur J Nucl Med; 1982; 7(7):294-7. PubMed ID: 6981508
[TBL] [Abstract][Full Text] [Related]
4. [Analysis of stereoisomers involved products of synthesized 18F-2-deoxy-2-fluoro-D-glucose by 1H-NMR spectroscopy].
Imazeki K; Erata T; Okada J; Yoshikawa K; Uno K; Arimizu N; Yoshizawa T; Nose T
Kaku Igaku; 1992 May; 29(5):639-42. PubMed ID: 1434079
[TBL] [Abstract][Full Text] [Related]
5. The use of 2-[18F]fluoro-2-deoxy-D-glucose as a potential in vitro agent for labelling human granulocytes for clinical studies by positron emission tomography.
Osman S; Danpure HJ
Int J Rad Appl Instrum B; 1992 Feb; 19(2):183-90. PubMed ID: 1601671
[TBL] [Abstract][Full Text] [Related]
6. Superimposition of PET images using 18F-fluorodeoxyglucose with magnetic resonance images in patients with pancreatic carcinoma.
Benyounes H; Smith FW; Campbell C; Evans NT; Norton MY; Mikecz P; Heys SD; Bruce D; Eremin O; Sharp PF
Nucl Med Commun; 1995 Jul; 16(7):575-80. PubMed ID: 7478396
[TBL] [Abstract][Full Text] [Related]
7. Oral 18F-fluoro-2-deoxyglucose for primate PET studies without behavioral restraint: demonstration of principle.
Martinez ZA; Colgan M; Baxter LR; Quintana J; Siegel S; Chatziioannou A; Cherry SR; Mazziotta JC; Phelps ME
Am J Primatol; 1997; 42(3):215-24. PubMed ID: 9209586
[TBL] [Abstract][Full Text] [Related]
8. Synthesis of 2-[18F]fluoro-2-deoxy-L-glucose and positron emission tomography studies in monkeys.
Meng J; Elmaleh DR; Jyawook S; Weiss S; Alpert NM; Babich JW; Tompkins RG; Fischman AJ
Nucl Med Biol; 1994 May; 21(4):633-40. PubMed ID: 9234321
[TBL] [Abstract][Full Text] [Related]
9. Determination of 18F-fluoro-2-deoxy-D-glucose rate constants in the anesthetized baboon brain with dynamic positron tomography.
Miyazawa H; Osmont A; Petit-Taboué MC; Tillet I; Travère JM; Young AR; Barré L; MacKenzie ET; Baron JC
J Neurosci Methods; 1993 Dec; 50(3):263-72. PubMed ID: 8152238
[TBL] [Abstract][Full Text] [Related]
10. Evidence for dissociation of insulin stimulation of blood flow and glucose uptake in human skeletal muscle: studies using [15O]H2O, [18F]fluoro-2-deoxy-D-glucose, and positron emission tomography.
Raitakari M; Nuutila P; Ruotsalainen U; Laine H; Teräs M; Iida H; Mäkimattila S; Utriainen T; Oikonen V; Sipilä H; Haaparanta M; Solin O; Wegelius U; Knuuti J; Yki-Järvinen H
Diabetes; 1996 Nov; 45(11):1471-7. PubMed ID: 8866549
[TBL] [Abstract][Full Text] [Related]
11. Does fluorine-18 fluorodeoxyglucose metabolic imaging of tumours benefit oncology?
Brock CS; Meikle SR; Price P
Eur J Nucl Med; 1997 Jun; 24(6):691-705. PubMed ID: 9169580
[TBL] [Abstract][Full Text] [Related]
12. Errors introduced by tissue heterogeneity in estimation of local cerebral glucose utilization with current kinetic models of the [18F]fluorodeoxyglucose method.
Schmidt K; Lucignani G; Moresco RM; Rizzo G; Gilardi MC; Messa C; Colombo F; Fazio F; Sokoloff L
J Cereb Blood Flow Metab; 1992 Sep; 12(5):823-34. PubMed ID: 1506447
[TBL] [Abstract][Full Text] [Related]
13. Myocardial viability: fluorine-18-deoxyglucose positron emission tomography in prediction of wall motion recovery after revascularization.
Knuuti MJ; Saraste M; Nuutila P; Härkönen R; Wegelius U; Haapanen A; Bergman J; Haaparanta M; Savunen T; Voipio-Pulkki LM
Am Heart J; 1994 Apr; 127(4 Pt 1):785-96. PubMed ID: 8154416
[TBL] [Abstract][Full Text] [Related]
14. [Uptake of FDG (2-fluoro-2-deoxy-D-glucose) as a tumor imaging agent into erythrocytes and accumulation of FDG in tumor cells].
Minosako Y; Nemoto M; Ino S; Shirakami Y; Kurami M
Kaku Igaku; 2003 Feb; 40(1):23-30. PubMed ID: 12701204
[TBL] [Abstract][Full Text] [Related]
15. Production of 18F-labelled 2-deoxy-2-fluoro-D-glucose and preliminary imaging results.
Mestelan G; Crouzel C; Cepeda C; Baron JC
Eur J Nucl Med; 1982; 7(8):379-86. PubMed ID: 6981509
[TBL] [Abstract][Full Text] [Related]
16. A computer simulation study on the input function sampling schedules in tracer kinetic modeling with positron emission tomography (PET).
Feng D; Wang X; Yan H
Comput Methods Programs Biomed; 1994 Nov; 45(3):175-86. PubMed ID: 7705075
[TBL] [Abstract][Full Text] [Related]
17. Positron-emission tomographic scanning of primary and metastatic breast carcinoma with the radiolabeled glucose analogue 2-deoxy-2-[18F]fluoro-D-glucose.
Wahl RL; Cody R; Hutchins G; Mudgett E
N Engl J Med; 1991 Jan; 324(3):200. PubMed ID: 1984203
[No Abstract] [Full Text] [Related]
18. Synthesis and purification of 2-deoxy-2-[18F]fluoro-D-glucose and 2-deoxy-2-[18F]fluoro-D-mannose: characterization of products by 1H- and 19F-NMR spectroscopy.
Oberdorfer F; Hull WE; Traving BC; Maier-Borst W
Int J Rad Appl Instrum A; 1986; 37(8):695-701. PubMed ID: 3021670
[TBL] [Abstract][Full Text] [Related]
19. Enhanced myocardial 18F-2-fluoro-2-deoxyglucose uptake after orthotopic heart transplantation assessed by positron emission tomography.
Rechavia E; de Silva R; Kushwaha SS; Rhodes CG; Araujo LI; Jones T; Maseri A; Yacoub MH
J Am Coll Cardiol; 1997 Aug; 30(2):533-8. PubMed ID: 9247529
[TBL] [Abstract][Full Text] [Related]
20. 18F-fluorodeoxyglucose PET scans in lung cancer.
Hughes JM
Thorax; 1996 Aug; 51 Suppl 2(Suppl 2):S16-22. PubMed ID: 8869347
[No Abstract] [Full Text] [Related]
[Next] [New Search]
